Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase I trial of HY209 Gel in healthy volunteers completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HY209 Gel

Snippet

Sponsor: Shaperon | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED | Results posted: 2020-10-19